SEC Form 4 · accession 0000921895-26-002105
Matinas BioPharma Holdings, Inc. · MTNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sanitam Partners LLC
10% Owner
Period of report
Jun 10, 2026
Accepted (ET)
Aug 13, 2026 · 4:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001582554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series C Convertible Preferred StockF2 | $0.586 | Jun 10, 2026 | J | 1,406 | D | Apr 4, 2025 | — | Common Stock | 2,399,318 | 0 | D |
| Warrants to Purchase Common Stock | $0.6446 | Jun 10, 2026 | J | 4,798,636 | D | Apr 8, 2025 | Apr 8, 2030 | Common Stock | 4,798,636 | 0 | D |
Explanation of responses
- F1On June 10, 2026, Sanitam Parnters LLC ("Sanitam") distributed its holdings in the Registrant's preferred stock and warrants to its members. As such Sanitam no longer beneficially owns any securities of the Registrant.
- F2The Series C Convertible Preferred Stock of the Registrant is perpetual and has no expiration date.